The global orthostatic hypotension drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Orthostatic hypotension, which is also known as postural hypotension, is a state of dizziness, that is caused due to low blood pressure. This commonly happens when a person stands up from a long sitting and feel dizzy. Orthostatic hypotension can be caused due to dehydration, heart problems, endocrine problems as well as nervous system disorders. Moreover, it has been found that nursing home elderly residents are more prone to orthostatic hypotension than people who stay living in the community.
The orthostatic hypotension disorder is most common in the elderly, teenagers and postpartum mothers. The major factors that are expected to fuel the global orthostatic hypotension market include the increasing aging population and increase in the prevalence of diabetes and heart disorders, along with the availability of an increasing number of treatments options. Moreover, increasing adoption and integration of technologies in healthcare premises along with the emergence of new entrants in the existing market are also the factors that are anticipated to boost the demand for treatment of orthostatic hypotension globally. The global orthostatic hypotension drugs market analysis includes some of the key market players such as Mylan Inc, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, F. Hoffman-La Roche, and Apotex, Inc., among others.
Market Coverage
Competitive Landscape: Mylan Inc, Upsher-Smith Laboratories, Chelsea Therapeutics, Amgen, F. Hoffman-La Roche, and Apotex, Inc., among others.
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Orthostatic Hypotension Drugs Market by Segment
By Product
• Droxidopa
• Fludrocortisone
• Indomethacin
• Midodrine Hydrochloride
• NSAIDs
• Pyridostigmine
By Test Type
• Blood tests
• ECG
• Echocardiogram
• Stress test
By End-Use
• Ambulatory Surgical Centers
• Clinics
• Diagnostic Centers
• Hospitals
Global Orthostatic Hypotension Drugs Market by Region
North America
Europe
Asia-Pacific
Rest of the World